May 27, 2010
Contact: Liz Dowling, (800) 386-0157
Dowling & Dennis Public Relations
Facilities Named "Centers of Excellence" for Advanced Breast Cancer Treatment
SAVI Device Makes Short-Term Therapy Available to More Women
ALISO VIEJO, Calif. - Nine facilities in the southern California area have been named Centers of Excellence in accelerated partial breast irradiation (APBI) for their use of the SAVIŽ applicator, an advanced therapy for breast cancer as part of breast conservation therapy. The SAVI applicator can provide important advantages for women with early-stage breast cancer.
The Center of Excellence designation recognizes these facilities' dedication to education, training and experience in APBI. To qualify, physicians, medical physicists and clinical staff were required to complete a comprehensive training and education program to demonstrate proficiency in delivering radiation therapy with SAVI. The facilities have also expressed a commitment to patient education, advocacy and awareness of advanced breast cancer treatments.
"Cianna Medical is proud to acknowledge the contributions these surgeons and radiation oncologists are making to the APBI field," said Jill Anderson, President and CEO of Cianna Medical. "They are changing how we care for women with early-stage breast cancer by recognizing the clinical benefits of more targeted radiation therapy and choosing to make it available to their patients."
Centers of Excellence:
UCSD Moores Cancer Center in La Jolla, CA
Oncology Therapies of Vista in Vista, CA
Compassionate Cancer Care in Las Vegas, NV
Surgeons receiving the Distinguished Achievement Award:
Deanna Attai, MD
Center for Breast Care in Burbank, CA
Kristi Funk, MD
Pink Lotus Breast Center in Beverly Hills, CA
John West, MD
Breast Care Imaging Center of Orange County in Orange, CA
Jeannie Shen, MD
UCLA Pasadena Oncology in Pasadena, CA
Cheryl Olson, MD
Surgical Associates of La Jolla in La Jolla, CA
Theodore Potruch, MD, in Las Vegas, NV
The commitment of these centers and physicians to offer the SAVI applicator extends the benefits of breast conservation therapy to a larger group of women and results in improved clinical outcomes.
Breast conservation therapy includes lumpectomy- the surgical removal of the cancerous tissue within the breast plus tissue immediately around the tumor - followed by radiation. This approach is an alternative to mastectomy, which removes the entire breast and is often followed by breast reconstruction.
The SAVI applicator delivers a form of radiation therapy known as breast brachytherapy. This approach, which targets the tumor site from inside the breast, is becoming a more widely used alternative to traditional radiation.
Breast brachytherapy typically involves two treatments per day for only five days. This shorter timeframe makes brachytherapy far more convenient than traditional, external-beam radiation. The latter is delivered five times a week and takes six or seven weeks.
Radiation treatment after a lumpectomy has traditionally involved irradiation of the entire breast with an external beam. Besides the inconvenience of the six-week-long regimen, many women must travel some distance to receive external-beam radiation. That can put additional stress on their families, jobs, and financial resources.
In addition to shortening the therapy time, breast brachytherapy with SAVI minimizes radiation exposure of healthy tissue, which reduces damage to critical structures such as the skin, heart, lungs and ribs.
About Cianna Medical, Inc.
Cianna Medical, Inc. is a medical device company focused on women's health and dedicated to the innovative treatment of early-stage breast cancer. The company manufactures and markets the SAVI breast brachytherapy applicator, for the delivery of radiation after lumpectomy surgery. The SAVI applicator allows precise sculpting of the radiation dose, and is designed to make the benefits of accelerated partial breast irradiation available to a greater number of women.
For more information, call (toll-free) 866-920-9444 or visit www.ciannamedical.com.